Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 753

Results For "CE"

8099 News Found

Pharma exports continue to climb in H1FY22
News | October 19, 2021

Pharma exports continue to climb in H1FY22

Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.


Domestic growth to the fore as US weakness persists: ICICI Direct
News | October 19, 2021

Domestic growth to the fore as US weakness persists: ICICI Direct

ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report


MSN Labs launches drug for diabetes management
Drug Approval | October 19, 2021

MSN Labs launches drug for diabetes management

The company claims that its Empagliflozin tablets are the most affordable in India


Granules gets ANDA approval for Dofetilide capsules
Drug Approval | October 18, 2021

Granules gets ANDA approval for Dofetilide capsules

The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm


WHO to take call on Covaxin's EUL on October 26th
News | October 18, 2021

WHO to take call on Covaxin's EUL on October 26th

The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17


U.S. FDA advisory committee recommends J&J booster dose
Biotech | October 18, 2021

U.S. FDA advisory committee recommends J&J booster dose

U.S. FDA to decide whether to authorize a booster dose in the coming days


GPT Healthcare to go public to fund expansion
Hospitals | October 18, 2021

GPT Healthcare to go public to fund expansion

The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India


Dr Reddy’s Lab launches carmustine in the US market
Drug Approval | October 16, 2021

Dr Reddy’s Lab launches carmustine in the US market

The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health


Govt. removes export curbs on Covid-19 kits
Policy | October 16, 2021

Govt. removes export curbs on Covid-19 kits

The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification


Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
Diagnostic Center | October 16, 2021

Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore

The revised deal involves a cash consideration only as against the earlier proposal of cash and equity